EUA
iHealth COVID-19 Antigen Rapid Test Pro
FDA Emergency Use Authorization · iHealth Labs, Inc. · Feb 1, 2024
Key facts
| Product | iHealth COVID-19 Antigen Rapid Test Pro |
|---|---|
| Company | iHealth Labs, Inc. |
| Product type | Lateral Flow, Visual Read, Serial Screening, Single Target |
| Date | Feb 1, 2024 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 10–99 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: